Xagenic

About:

Xagenic is a molecular diagnostics company developing on-demand molecular testing, facilitating faster treatment decisions for patients.

Website: http://www.xagenic.com

Top Investors: BDC Venture Capital, MaRS Investment Accelerator Fund, Government of Canada, Qiagen, Toronto Innovation Acceleration Partners

Description:

Xagenic Inc., a Toronto, Canada-based molecular diagnostics company developing new technology for decentralized, rapid diagnostic testing, and a true point-of-care platform. Our aim is to enable on-demand, near-patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of the first consultation. This will dramatically improve patient care and reduce health care costs. Xagenic has adapted this technology to permit rapid, enzyme-free detection of nucleic acids from clinical samples. We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.